PBH Prestige Consumer Healthcare Inc. Common Stock
NYSE · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 6, 2026PBH Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
PBH Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Prestige Consumer Healthcare Inc. Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Prestige Brands Holdings, Inc. tezgah üstü sağlık ve ev temizlik ürünlerini pazarlayan ve dağıtan bir Amerikan şirketidir. 1996 yılında Medtech Products, Inc., Prestige Brands International ve Spic and Span şirketinin birleşmesiyle kurulmuştur. Şirket merkezi Tarrytown, New York'ta bulunmaktadır.
Prestige Brands'ın sahip olduğu markalar arasında Kloraseptik boğaz ağrısı ürünleri, Clear Eyes, Compound W siğil tedavisi, Dramamine hareket hastalığı tedavisi, Efferdent protez bakımı, Luden's boğazı damlaları, BC Tozu ve Goody'nin Baş Ağrısı Tozu, Pediacare & Little Remedies çocuk OTC ürünleri, Beano, Comet ve Spic and Span ev temizlik ürünleri bulunmaktadır.
Tarihi
Prestige Brands Holdings, Inc., önde gelen, çoğunlukla ihmal edilen ancak sağlıklı tüketici markalarını elde etmek, yeniden canlandırmak ve sınırlamak için kuruldu. 2004 yılında MidOcean Partners, GTCH Golder Rauner'a Prestige Markalarını sattı.
Şirket, 2010 yılında Blacksmith Brands'ın beş marka portföyünü satın aldı.
Şirket, Aralık 2011'de, GlaxoSmithKline'dan BC Powder, Beano, Ecotrin, Fiber Choice, Goody's Powder, Sominex and Tagamet'i içeren 6 markayı 660 Milyon Dolara satın almayı kabul etti.
Prestige Brands Holdings, Inc., 2013 yılında, çocuklar ve yetişkinler için sağlık markalarının özel bir pazarlamacısı ve distribütörü olan Bondi Junction'ın Care Pharmaceuticals'ı (New South Wales, Avustralya) satın aldı.
2014 yılında şirket, Yeni Zelanda'da ve Avustralya'da Hydralyte'ı Hydration Pharmaceuticals Trust'tan satın aldı. Hidrolit, Avustralya ve Yeni Zelanda'da lider oral rehidrasyon ürünüdür.
2014 yılının Nisan ayında, Prestige Brands Holdings, Inc., kadın bakımı ve diğer reçetesiz sağlık ürünleri pazarlamacısı ve dağıtıcısı olan Insight Pharmaceuticals Corporation'ı 750 milyon dolara satın almak için kesin bir anlaşma imzaladığını açıkladı.
Kasım 2015'te Prestige Brands Holdings, Inc., özel bir pazarlamacı ve ağız bakım ürünleri dağıtıcısı olan DenTek'i 225 milyon dolara nakit olarak satın almak için kesin bir anlaşma imzaladığını açıkladı.
Aralık 2016'da Monistat, Dramamine ve Luden's markalarına ev sahipliği yapan Prestige Brands Holdings Inc., C.B. Fleet Co. şirketini özel sermaye şirketi Gryphon Investors'tan yaklaşık 825 milyon dolara satın almayı kabul etti.
Prestige, 2009 yılında Denorex ve Prell marka şampuanlarını sattı. O zamandan beri Phazyme (2012); Fiber Choice, PediaCare, New-Skin ve Dermoplast (2016) çıkarıldı.
Ürünler
Kaynakça
Dış bağlantılar
Sitesi 25 Mart 2019 tarihinde Wayback Machine sitesinde arşivlendi.
Kaynak: Wikipedia, CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | PBH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 12.75Y ort. ≈5.5 | ≈5.5 | · | · | |
| F/S (TTM) | 2.35Y ort. ≈3.3 | ≈3.3 | · | · | |
| F/D (MRQ) | 1.35Y ort. ≈2.2 | ≈2.2 | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | 10.85Y ort. ≈15.4 | ≈15.4 | · | · | |
| Fiyat / Nakit Akışı (TTM) | 10.25Y ort. ≈14.9 | ≈14.9 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | -1.9 | · | · | · | |
| PEG Ratio (PEG Oranı) | ≈3.4 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | PBH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Brüt Kar Marjı (TTM) | 53.5%5Y ort. ≈55.7% | ≈55.7% | · | · | |
| Faaliyet Kâr Marjı (TTM) | 26.3%5Y ort. ≈23.4% | ≈23.4% | · | · | |
| FAVÖK Marjı (TTM) | 29.2%5Y ort. ≈26.2% | ≈26.2% | · | · | |
| Pretax Margin (Vergi Öncesi Kar Marjı) | 23.6%5Y ort. ≈17.8% | ≈17.8% | · | · | |
| Net Kâr Marjı (TTM) | 15.6%5Y ort. ≈13.3% | ≈13.3% | · | · | |
| ROA (TTM) | 4.3%5Y ort. ≈4.3% | ≈4.3% | · | · | |
| ROE (TTM) | 9.1%5Y ort. ≈8.6% | ≈8.6% | · | · | |
| ROIC | 12.1%5Y ort. ≈8.6% | ≈8.6% | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | PBH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 1.15Y ort. ≈0.8 | ≈0.8 | · | · | |
| Cari Oran (MRQ) | 3.25Y ort. ≈3.1 | ≈3.1 | · | · | |
| Quick Ratio (Cari Oran) | 2.15Y ort. ≈1.9 | ≈1.9 | · | · | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | 1.05Y ort. ≈0.8 | ≈0.8 | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | PBH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -4.3%5Y ort. ≈3.1% | ≈3.1% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -1.2%5Y ort. ≈2.1% | ≈2.1% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 2.9% | · | · | · | |
| EPS YoY (EPS YB) | -8.9%5Y ort. ≈6.1% | ≈6.1% | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | -11.3%5Y ort. ≈5.3% | ≈5.3% | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | 2.0% | · | · | · | |
| EPS CAGR 5Y (EPS Bileşik Yıllık Büyüme Oranı 5Y) | 3.8% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | 1.5% | · | · | · | |
| Net Income CAGR 5Y (Net Gelir Bileşik Yıllık Büyüme Oranı 5Y) | 2.9% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | PBH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.35Y ort. ≈0.3 | ≈0.3 | · | · | |
| Inventory Turnover (Stok Devir Hızı) | 3.25Y ort. ≈3.5 | ≈3.5 | · | · | |
| Receivables Turnover (Alacak Devir Hızı) | 5.65Y ort. ≈6.8 | ≈6.8 | · | · | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$1.2M | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | $0.98 | $0.89 | 10.0% | |
| 31 Mart 2026 | $1.23 | $1.40 | -12.4% | |
| 31 Aralık 2025 | $1.14 | $1.16 | -1.4% | |
| 30 Eylül 2025 | $1.07 | $0.98 | 9.2% | |
| 30 Haziran 2025 | $0.95 | $1.01 | -6.0% | |
| 31 Mart 2025 | $1.32 | $1.31 | 0.64% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943M | $963M | $976M | $1.04B | $882M | $806M | $715M | |
| Cost of Revenue | $493M | $503M | $501M | $502M | $466M | $396M | $411M | $420M | $465M | $382M | $339M | · | |
| Gross Profit | $596M | $634M | $624M | $625M | $621M | $547M | $552M | $556M | $577M | $500M | $467M | $406M | |
| SG&A Expense | $116M | $108M | $106M | $107M | $107M | $83M | $89M | $90M | $85M | $89M | $72M | $81M | |
| Operating Expenses | $286M | $298M | $282M | $648M | $291M | $250M | $261M | $488M | $361M | $295M | $207M | $199M | |
| Operating Income | $309M | $337M | $342M | $-22M | $330M | $297M | $291M | $68M | $215M | $206M | $260M | $208M | |
| Interest Expense | · | $2M | $5M | $4M | · | · | · | · | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | $342.0K | $217.0K | $388.0K | $203.0K | $162.0K | $92.0K | |
| Other Non-op | $-10M | $-5M | $756.0K | $-2M | $-1M | $1M | $-2M | $-476.0K | $392.0K | $-30.0K | · | · | |
| Pretax Income | $257M | $284M | $276M | $-94M | $262M | $204M | $191M | $-38M | $107M | $111M | $157M | $127M | |
| Income Tax | $67M | $70M | $67M | $-12M | $57M | $39M | $49M | $-2M | $-232M | $41M | $57M | $49M | |
| Net Income | $190M | $215M | $209M | $-82M | $205M | $165M | $142M | $-36M | $340M | $69M | $100M | $78M | |
| EPS (Basic) | $3.93 | $4.32 | $4.21 | $-1.65 | $4.09 | $3.28 | $2.81 | $-0.69 | $6.40 | $1.31 | $1.89 | $1.50 | |
| EPS (Diluted) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 | $3.25 | $2.78 | $-0.69 | $6.34 | $1.30 | $1.88 | $1.49 | |
| Shares (Basic) | 48,456,000 | 49,697,000 | 49,757,000 | 49,889,000 | 50,259,000 | 50,210,000 | 50,723,000 | 52,068,000 | 53,099,000 | 52,976,000 | 52,754,000 | 52,170,000 | |
| Shares (Diluted) | 48,720,000 | 50,080,000 | 50,178,000 | 49,889,000 | 50,842,000 | 50,605,000 | 51,140,000 | 52,068,000 | 53,526,000 | 53,362,000 | 53,143,000 | 52,670,000 | |
| EBITDA | $341M | $367M | $373M | $10M | $362M | $328M | $320M | $99M | $249M | $231M | $284M | $225M |
Bilanço
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $64M | $98M | $46M | $58M | $27M | $32M | $95M | $28M | $33M | $42M | $27M | $21M | |
| Receivables | $192M | $194M | $177M | $167M | $139M | $115M | $151M | $149M | $141M | $137M | $95M | $88M | |
| Inventory | $159M | $148M | $139M | $162M | $120M | $115M | $116M | $120M | $119M | $116M | $91M | $74M | |
| Prepaid Expense | $17M | $8M | $13M | $4M | $6M | $8M | $4M | $5M | $12M | $40M | $25M | $10M | |
| Current Assets | $431M | $448M | $375M | $392M | $293M | $270M | $366M | $301M | $303M | $334M | $249M | $202M | |
| PP&E (Net) | $122M | $75M | $77M | $70M | $71M | $70M | $56M | $51M | $53M | $51M | $16M | $14M | |
| PP&E (Gross) | $211M | $156M | $149M | $137M | $132M | $124M | $102M | $90M | $83M | $71M | $30M | $26M | |
| Accum. Depreciation | $89M | $81M | $72M | $67M | $61M | $54M | $46M | $39M | $30M | $20M | $15M | $12M | |
| Goodwill | $581M | $527M | $528M | $528M | $579M | $578M | $575M | $579M | $620M | $615M | $360M | $291M | |
| Intangibles | $2.30B | $2.30B | $2.32B | $2.34B | $2.70B | $2.48B | $2.48B | $2.51B | $2.78B | $2.90B | $2.32B | $2.13B | |
| Other Non-current Assets | $11M | $3M | $6M | $3M | $3M | $3M | $3M | $3M | $4M | $7M | $1M | $1M | |
| Total Assets | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B | $3.43B | $3.51B | $3.44B | $3.76B | $3.91B | $2.95B | $2.64B | |
| Accounts Payable | $23M | $19M | $39M | $63M | $56M | $46M | $62M | $57M | $61M | $70M | $38M | $46M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $41M | |
| Current Liabilities | $121M | $107M | $117M | $161M | $143M | $122M | $150M | $127M | $123M | $162M | $107M | $99M | |
| Capital Leases | $21M | $23M | $8M | $10M | $16M | $20M | $25M | $0 | · | · | · | · | |
| Deferred Tax | $447M | $420M | $404M | $380M | $445M | $434M | $408M | $400M | $443M | $715M | $470M | $352M | |
| Other Non-current Liabilities | $6M | $5M | $9M | $8M | $7M | $9M | $25M | $20M | $23M | $18M | $3M | $2M | |
| Total Liabilities | $1.61B | $1.57B | $1.66B | $1.91B | $2.09B | $2.07B | $2.34B | $2.35B | $2.58B | $3.09B | $2.20B | $2.01B | |
| Long-term Debt | $994M | $992M | $1.13B | $1.35B | $1.48B | $1.48B | $1.73B | $1.80B | $1.99B | · | · | $1.56B | |
| Total Debt | · | · | $1.13B | $1.35B | $1.48B | $1.48B | $1.73B | $1.80B | $1.99B | $2.19B | $1.63B | $1.59B | |
| Common Stock | $562.0K | $560.0K | $555.0K | $548.0K | $544.0K | $540.0K | $538.0K | $536.0K | $534.0K | $533.0K | $530.0K | $525.0K | |
| Paid-in Capital | $609M | $593M | $567M | $535M | $516M | $500M | $488M | $479M | $469M | $458M | $445M | $427M | |
| Retained Earnings | $1.75B | $1.56B | $1.34B | $1.13B | $1.21B | $1.01B | $844M | $702M | $736M | $397M | $327M | $227M | |
| Treasury Stock | $439M | $277M | $220M | $189M | $134M | $131M | $118M | $60M | $8M | $7M | $5M | $3M | |
| AOCI | $-28M | $-38M | $-34M | $-32M | $-19M | $-20M | $-44M | $-26M | $-19M | $-26M | $-24M | $-23M | |
| Stockholders' Equity | $1.89B | $1.83B | $1.66B | $1.45B | $1.58B | $1.36B | $1.17B | $1.10B | $1.18B | $823M | $744M | $628M | |
| Liabilities + Equity | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B | $3.43B | $3.51B | $3.44B | $3.76B | $3.91B | $2.95B | $2.64B | |
| Shares Outstanding | 56,211,000 | 56,010,000 | 55,501,000 | 54,857,000 | 54,430,000 | 53,999,000 | 53,805,000 | 53,670,000 | 53,396,000 | 53,287,000 | 53,066,000 | 52,562,000 |
Nakit Akışı
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $31M | $30M | $31M | $33M | $32M | $30M | $29M | $32M | $33M | $26M | $24M | $18M | |
| Stock-based Comp | $11M | $11M | $14M | $12M | · | · | · | · | · | $8M | $10M | $7M | |
| Deferred Tax | $23M | $14M | $23M | $-61M | $10M | $19M | $14M | $-41M | $-269M | $-6M | $46M | $29M | |
| Amort. of Intangibles | $18M | $18M | $20M | $22M | $21M | $20M | $20M | $22M | $23M | $20M | $18M | $13M | |
| Other Non-cash | $3M | $-19M | $-14M | $340M | $12M | $22M | $32M | $234M | $106M | $50M | $-5M | $24M | |
| Operating Cash Flow | $258M | $252M | $249M | $230M | $260M | $236M | $217M | $189M | $210M | $149M | $176M | $156M | |
| CapEx | $11M | $8M | $10M | $8M | $10M | $22M | $15M | $10M | $13M | $3M | $4M | $6M | |
| Investing Cash Flow | $-137M | $-17M | $-20M | $-12M | $-257M | $-22M | $-17M | $55M | $-12M | $-695M | $-223M | $-805M | |
| Stock Repurchased | $156M | $52M | $25M | $50M | $0 | $12M | $57M | $50M | $0 | $0 | · | · | |
| Net Stock Activity | $-156M | $-52M | $-25M | $-50M | $0 | $-12M | $-57M | $-50M | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Financing Cash Flow | $-156M | $-182M | $-241M | $-186M | $-8M | $-279M | $-131M | $-249M | $-209M | $561M | $52M | $643M | |
| Net Change in Cash | $-34M | $51M | $-12M | $31M | $-5M | $-62M | $67M | $-5M | $-9M | $15M | $6M | $-7M | |
| Taxes Paid | $46M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $246M | $243M | $239M | $222M | $250M | $213M | $203M | $179M | $198M | $145M | $171M | $150M | |
| Levered FCF | · | $242M | $235M | · | · | · | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.7% | 55.8% | 55.5% | 55.5% | 57.1% | 58.0% | 57.3% | 56.9% | 55.4% | 56.7% | 58.0% | 56.9% | |
| Operating Margin | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% | 31.5% | 30.2% | 6.9% | 20.7% | 23.3% | 32.3% | 29.1% | |
| Net Margin | 17.5% | 18.9% | 18.6% | -7.3% | 18.9% | 17.5% | 14.8% | -3.7% | 32.6% | 7.9% | 12.4% | 11.0% | |
| Pretax Margin | 23.6% | 25.0% | 24.5% | -8.3% | 24.1% | 21.6% | 19.9% | -3.9% | 10.3% | 12.6% | 19.5% | 17.9% | |
| EBITDA Margin | 31.3% | 32.2% | 33.1% | 0.91% | 33.3% | 34.7% | 33.2% | 10.2% | 23.9% | 26.2% | 35.2% | 31.6% | |
| ROA | 5.5% | 6.4% | 6.3% | -2.3% | 5.8% | 4.7% | 4.1% | -0.99% | 8.8% | 2.0% | 3.6% | 3.5% | |
| ROE | 10.2% | 11.8% | 12.9% | -5.2% | 13.3% | 12.3% | 12.2% | -3.1% | 33.9% | 8.9% | 14.6% | 13.1% | |
| ROIC | 12.1% | 13.9% | 9.3% | -0.70% | 8.5% | 8.5% | 7.5% | 2.2% | 21.6% | 4.3% | 7.0% | 5.8% |
Likidite ve Solventlik
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 4.2 | 3.2 | 2.4 | 2.0 | 2.2 | 2.4 | 2.4 | 2.5 | 2.1 | 2.3 | 2.0 | |
| Quick Ratio | 2.1 | 2.7 | 1.9 | 1.4 | 1.2 | 1.2 | 1.6 | 1.4 | 1.4 | 1.1 | 1.1 | 1.1 | |
| Debt / Equity | · | · | 0.7 | 0.9 | 0.9 | 1.1 | 1.5 | 1.6 | 1.7 | 2.7 | 2.2 | 2.5 | |
| LT Debt / Equity | · | · | 0.7 | 0.9 | 0.9 | 1.1 | 1.5 | 1.6 | 1.7 | 2.7 | 2.2 | 2.5 | |
| Interest Coverage | · | 187.1 | 65.9 | · | · | · | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
| Inventory Turnover | 3.2 | 3.5 | 3.3 | 3.6 | 4.0 | 3.4 | 3.5 | 3.6 | 4.0 | · | · | · | |
| Receivables Turnover | 5.6 | 6.1 | 6.5 | 7.4 | 8.6 | 7.1 | 6.4 | 6.6 | 7.5 | 7.6 | 8.8 | 9.3 |
Hisse Başına
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $33.58 | $32.76 | $29.82 | $26.38 | $28.98 | $25.15 | $21.76 | $20.42 | $22.07 | $15.44 | $14.03 | $11.94 | |
| Revenue / Share | $22.35 | $22.72 | $22.43 | $22.60 | $21.38 | $18.64 | $18.83 | $18.74 | $19.45 | $16.53 | $15.17 | $13.55 | |
| Cash Flow / Share | $5.29 | $5.02 | $4.96 | $4.60 | $5.11 | $4.66 | $4.25 | $3.64 | $3.93 | $2.77 | $3.28 | $2.97 | |
| Cash / Share | $1.14 | $1.75 | $0.84 | $1.07 | $0.50 | $0.60 | $1.76 | $0.51 | $0.61 | $0.79 | $0.51 | $0.41 | |
| EPS (TTM) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 | $3.25 | $2.78 | $-0.69 | $6.34 | $1.30 | $1.88 | $1.49 |
Büyüme Oranları
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -4.3% | 1.1% | -0.21% | 3.8% | 15.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.2% | 1.5% | 6.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.9% | 2.9% | · | · | 24.3% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 2.0% | 8.7% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 3.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -11.3% | 2.5% | · | · | 24.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 1.5% | 8.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 2.9% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943M | $963M | $976M | $1.04B | $882M | $806M | $715M | |
| Net Income TTM | $190M | $215M | $209M | $-82M | $205M | $165M | $142M | $-36M | $340M | $69M | $100M | $78M | |
| Market Cap | $3.33B | $4.82B | $4.03B | $3.44B | $2.88B | $2.38B | $1.97B | $1.61B | $1.80B | $2.96B | $2.83B | $2.25B | |
| Enterprise Value | · | · | $5.11B | $4.72B | $4.33B | $3.83B | $3.61B | $3.38B | $3.76B | $5.11B | $4.43B | $3.82B | |
| P/E | 15.2 | 20.0 | 17.4 | -38.0 | 13.1 | 13.6 | 13.2 | -43.3 | 5.3 | 42.7 | 28.4 | 28.8 | |
| P/S | 3.1 | 4.2 | 3.6 | 3.0 | 2.7 | 2.5 | 2.0 | 1.6 | 1.7 | 3.4 | 3.5 | 3.2 | |
| P/B | 1.8 | 2.6 | 2.4 | 2.4 | 1.8 | 1.8 | 1.7 | 1.5 | 1.5 | 3.6 | 3.8 | 3.6 | |
| P / Cash Flow | 12.9 | 19.1 | 16.2 | 15.0 | 11.1 | 10.1 | 9.1 | 8.5 | 8.6 | 20.0 | 16.2 | 14.4 | |
| P / FCF | 13.5 | 19.8 | 16.8 | 15.5 | 11.5 | 11.2 | 9.7 | 9.0 | 9.1 | 20.4 | 16.6 | 15.0 | |
| EV / EBITDA | · | · | 13.7 | 462.6 | 12.0 | 11.7 | 11.3 | 34.0 | 15.1 | 22.1 | 15.6 | 17.0 | |
| EV / FCF | · | · | 21.3 | 21.3 | 17.3 | 17.9 | 17.8 | 18.9 | 19.0 | 35.3 | 25.9 | 25.5 | |
| EV / Revenue | · | · | 4.5 | 4.2 | 4.0 | 4.1 | 3.7 | 3.5 | 3.6 | 5.8 | 5.5 | 5.3 | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | 0.00% | 0.00% | |
| Earnings Yield | 6.6% | 5.0% | 5.8% | -2.6% | 7.6% | 7.4% | 7.6% | -2.3% | 18.8% | 2.3% | 3.5% | 3.5% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | 0.00% | 0.00% | |
| Annual Payout | · | · | · | · | · | · | · | · | · | · | $0 | $0 |
Gelir Tablosu
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $266M | $282M | $283M | $274M | $250M | $297M | $290M | $284M | $267M | $277M | $283M | $286M | $279M | $286M | $276M | $289M | |
| Cost of Revenue | $130M | $135M | $126M | $123M | $109M | $127M | $129M | $126M | $121M | $125M | $125M | $126M | $125M | $132M | $125M | $128M | |
| Gross Profit | $136M | $146M | $157M | $152M | $140M | $170M | $161M | $157M | $146M | $152M | $158M | $160M | $155M | $154M | $150M | $161M | |
| SG&A Expense | $43M | $30M | $30M | $28M | $28M | $27M | $26M | $26M | $29M | $26M | $26M | $26M | $28M | $28M | $27M | $26M | |
| Operating Expenses | $84M | $71M | $75M | $72M | $69M | $82M | $69M | $73M | $74M | $70M | $71M | $72M | $69M | $435M | $63M | $77M | |
| Operating Income | $53M | $75M | $82M | $80M | $72M | $88M | $92M | $84M | $72M | $82M | $87M | $88M | $85M | $-281M | $87M | $84M | |
| Other Non-op | $-34.0K | $708.0K | $-10M | $-501.0K | $224.0K | $-4M | $-353.0K | $-395.0K | $-496.0K | $429.0K | $-682.0K | $-229.0K | $1M | $451.0K | $-1M | $-812.0K | |
| Income Tax | $9M | $11M | $15M | $27M | $14M | $24M | $19M | $17M | $9M | $18M | $17M | $17M | $15M | $-59M | $16M | $16M | |
| Net Income | $29M | $54M | $47M | $42M | $47M | $50M | $61M | $54M | $49M | $49M | $53M | $54M | $53M | $-241M | $52M | $51M | |
| EPS (Basic) | $0.61 | $1.13 | $0.98 | $0.86 | $0.96 | $1.01 | $1.23 | $1.10 | $0.98 | $0.99 | $1.07 | $1.08 | $1.07 | $-4.82 | $1.05 | $1.02 | |
| EPS (Diluted) | $0.61 | $1.13 | $0.97 | $0.86 | $0.95 | $1.00 | $1.22 | $1.09 | $0.98 | $0.98 | $1.06 | $1.07 | $1.06 | $-4.80 | $1.04 | $1.02 | |
| Shares (Basic) | 47,462,000 | · | 47,880,000 | 49,025,000 | 49,475,000 | · | 49,597,000 | 49,652,000 | 49,886,000 | · | 49,740,000 | 49,687,000 | 49,767,000 | · | 49,693,000 | 49,804,000 | |
| Shares (Diluted) | 47,604,000 | · | 48,087,000 | 49,264,000 | 49,833,000 | · | 49,993,000 | 49,998,000 | 50,267,000 | · | 50,125,000 | 50,081,000 | 50,196,000 | · | 50,186,000 | 50,265,000 | |
| EBITDA | $61M | · | $82M | $80M | $79M | · | $92M | $84M | $80M | · | $87M | $88M | $93M | · | $87M | $84M |
Bilanço
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $64M | $62M | $119M | $140M | $98M | $51M | $52M | $34M | $46M | $64M | $60M | $55M | · | $86M | $42M | |
| Receivables | $187M | $192M | $190M | $199M | $168M | $194M | $167M | $164M | $172M | $177M | $174M | $158M | $158M | · | $157M | $146M | |
| Inventory | $190M | $159M | $164M | $159M | $153M | $148M | $152M | $156M | $152M | $139M | $149M | $161M | $170M | · | $159M | $141M | |
| Prepaid Expense | $30M | $17M | $17M | $20M | $19M | $8M | $8M | $9M | $11M | $13M | $7M | $8M | $9M | · | $7M | $8M | |
| Current Assets | $497M | $431M | $433M | $497M | $481M | $448M | $377M | $381M | $369M | $375M | $394M | $388M | $392M | · | $409M | $337M | |
| PP&E (Net) | $117M | $122M | $128M | $73M | $74M | $75M | $74M | $75M | $75M | $77M | $70M | $71M | $70M | · | $70M | $70M | |
| PP&E (Gross) | · | $211M | · | · | · | $156M | · | · | · | $149M | · | · | · | · | · | · | |
| Accum. Depreciation | · | $89M | · | · | · | $81M | · | · | · | $72M | · | · | · | · | · | · | |
| Goodwill | $651M | $581M | $581M | $528M | $528M | $527M | $527M | $529M | $528M | $528M | $528M | $527M | $527M | $528M | $577M | $576M | |
| Intangibles | $3.24B | $2.30B | $2.30B | $2.29B | $2.29B | $2.30B | $2.31B | $2.32B | $2.32B | $2.32B | $2.33B | $2.33B | $2.34B | · | $2.67B | $2.67B | |
| Other Non-current Assets | $13M | $11M | $4M | $3M | $3M | $3M | $6M | $7M | $6M | $6M | $6M | $4M | $3M | · | $3M | $3M | |
| Total Assets | $4.57B | $3.49B | $3.49B | $3.44B | $3.43B | $3.40B | $3.33B | $3.32B | $3.31B | $3.32B | $3.34B | $3.33B | $3.35B | · | $3.75B | $3.68B | |
| Accounts Payable | $37M | $23M | $43M | $42M | $22M | $19M | $20M | $31M | $40M | $39M | $39M | $44M | $58M | · | $64M | $56M | |
| Current Liabilities | $154M | $121M | $140M | $135M | $110M | $107M | $103M | $107M | $114M | $117M | $127M | $130M | $147M | · | $160M | $152M | |
| Capital Leases | $19M | $21M | $18M | $20M | $21M | $23M | $24M | $7M | $7M | $8M | $6M | $7M | $8M | · | $12M | $13M | |
| Deferred Tax | $449M | $447M | $449M | $445M | $427M | $420M | $413M | $415M | $409M | $404M | $397M | $388M | $384M | · | $456M | $443M | |
| Other Non-current Liabilities | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $9M | $9M | $9M | $8M | · | $9M | $9M | |
| Total Liabilities | $2.65B | $1.61B | $1.67B | $1.62B | $1.58B | $1.57B | $1.54B | $1.59B | $1.63B | $1.66B | $1.74B | $1.80B | $1.87B | · | $2.06B | $2.06B | |
| Long-term Debt | $2.02B | $994M | $1.03B | $993M | $993M | $992M | $992M | $1.05B | $1.09B | $1.13B | $1.20B | $1.26B | $1.32B | · | $1.42B | $1.44B | |
| Total Debt | $2.02B | · | · | · | · | · | $1.00B | $1.06B | $1.10B | · | $1.21B | $1.27B | $1.33B | · | $1.44B | $1.46B | |
| Common Stock | $563.0K | $562.0K | $562.0K | $562.0K | $561.0K | $560.0K | $559.0K | $557.0K | $557.0K | $555.0K | $553.0K | $552.0K | $552.0K | · | $548.0K | $547.0K | |
| Paid-in Capital | $613M | $609M | $605M | $603M | $600M | $593M | $588M | $577M | $573M | $567M | $556M | $552M | $547M | · | $533M | $524M | |
| Retained Earnings | $1.78B | $1.75B | $1.69B | $1.65B | $1.60B | $1.56B | $1.51B | $1.44B | $1.39B | $1.34B | $1.29B | $1.24B | $1.19B | · | $1.37B | $1.32B | |
| Treasury Stock | $442M | $439M | $439M | $392M | $316M | $277M | $266M | $263M | $252M | $220M | $220M | $220M | $220M | · | $189M | $189M | |
| AOCI | $-30M | $-28M | $-30M | $-32M | $-32M | $-38M | $-40M | $-27M | $-31M | $-34M | $-29M | $-36M | $-32M | · | $-29M | $-36M | |
| Stockholders' Equity | $1.92B | $1.89B | $1.83B | $1.82B | $1.86B | $1.83B | $1.79B | $1.73B | $1.68B | $1.66B | $1.60B | $1.54B | $1.48B | $1.45B | $1.69B | $1.62B | |
| Liabilities + Equity | $4.57B | $3.49B | $3.49B | $3.44B | $3.43B | $3.40B | $3.33B | $3.32B | $3.31B | $3.32B | $3.34B | $3.33B | $3.35B | · | $3.75B | $3.68B | |
| Shares Outstanding | 56,312,000 | 56,211,000 | 56,198,000 | 56,196,000 | 56,171,000 | 56,010,000 | 55,939,000 | 55,769,000 | 55,717,000 | 55,501,000 | 55,329,000 | 55,291,000 | 55,220,000 | 54,857,000 | 54,852,000 | 54,690,000 |
Nakit Akışı
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Stock-based Comp | $4M | $3M | $3M | $2M | $4M | $3M | $3M | $2M | $3M | $4M | $2M | $4M | $4M | $3M | $2M | $3M | |
| Deferred Tax | $193.0K | $-4M | $4M | $17M | $6M | $7M | $3M | $4M | $612.0K | $8M | $5M | $5M | $4M | $-75M | $10M | $3M | |
| Amort. of Intangibles | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | · | $6M | $6M | |
| Other Non-cash | $29M | · | · | · | $14M | · | · | · | $-6M | · | · | · | $-21M | · | · | · | |
| Operating Cash Flow | $71M | $43M | $78M | $57M | $79M | $62M | $65M | $70M | $55M | $67M | $71M | $62M | $48M | $59M | $55M | $58M | |
| CapEx | $4M | $5M | $3M | $2M | $838.0K | $3M | $2M | $2M | $1M | $3M | $2M | $3M | $1M | $3M | $2M | $2M | |
| Investing Cash Flow | $-1.06B | $-3M | $-129M | $-3M | $-2M | $-3M | $-10M | $-2M | $-2M | $-15M | $-4M | $-3M | $2M | $-6M | $-2M | $-2M | |
| Debt Issued | $1.04B | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $1.04B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $0 | $690.0K | $46M | $75M | $35M | $11M | $2M | $12M | $26M | $0 | $0 | $0 | $25M | $0 | $0 | $12M | |
| Net Stock Activity | $0 | · | · | · | $-35M | · | · | · | $-26M | · | · | · | $-25M | · | · | · | |
| Financing Cash Flow | $1.02B | $-38M | $-7M | $-75M | $-36M | $-11M | $-54M | $-51M | $-66M | $-68M | $-65M | $-54M | $-54M | $-80M | $-10M | $-48M | |
| Net Change in Cash | $25M | $1M | $-57M | $-20M | $42M | $47M | $-666.0K | $17M | $-12M | $-17M | $4M | $5M | $-4M | $-28M | $44M | $7M | |
| Free Cash Flow | $67M | · | · | · | $78M | · | · | · | $54M | · | · | · | $47M | · | · | · |
Kârlılık
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 51.2% | · | 55.5% | 55.3% | 56.2% | · | 55.5% | 55.5% | 54.7% | · | 55.9% | 55.9% | 55.4% | · | 54.6% | 55.7% | |
| Operating Margin | 19.8% | · | 29.1% | 29.1% | 28.8% | · | 31.7% | 29.7% | 27.0% | · | 30.7% | 30.8% | 30.5% | · | 31.6% | 29.2% | |
| Net Margin | 11.0% | · | 16.5% | 15.4% | 19.0% | · | 21.0% | 19.2% | 18.4% | · | 18.8% | 18.7% | 19.1% | · | 18.9% | 17.6% | |
| EBITDA Margin | 23.1% | · | 29.1% | 29.1% | 31.8% | · | 31.7% | 29.7% | 30.0% | · | 30.7% | 30.8% | 33.2% | · | 31.6% | 29.2% | |
| ROA | 0.73% | · | 1.4% | 1.2% | 1.4% | · | 1.8% | 1.6% | 1.5% | · | 1.5% | 1.5% | 1.5% | · | 1.4% | 1.4% | |
| ROE | 1.6% | · | 2.6% | 2.4% | 2.7% | · | 3.6% | 3.3% | 3.1% | · | 3.2% | 3.4% | 3.5% | · | 3.2% | 3.3% |
Likidite ve Solventlik
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | · | 3.1 | 3.7 | 4.4 | · | 3.7 | 3.6 | 3.2 | · | 3.1 | 3.0 | 2.7 | · | 2.6 | 2.2 | |
| Quick Ratio | 1.8 | · | 1.8 | 2.4 | 2.8 | · | 2.1 | 2.0 | 1.8 | · | 1.9 | 1.7 | 1.4 | · | 1.5 | 1.2 | |
| Debt / Equity | 1.1 | · | · | · | · | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 0.9 | |
| LT Debt / Equity | 1.0 | · | · | · | · | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 0.9 |
Verimlilik
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Inventory Turnover | 0.8 | · | 0.8 | 0.8 | 0.7 | · | 0.9 | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 1.0 | |
| Receivables Turnover | 1.5 | · | 1.6 | 1.5 | 1.5 | · | 1.7 | 1.8 | 1.6 | · | 1.7 | 1.9 | 1.8 | · | 1.9 | 2.0 |
Hisse Başına
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $34.04 | · | $32.55 | $32.48 | $33.03 | · | $31.97 | $31.05 | $30.17 | · | $28.93 | $27.78 | $26.81 | · | $30.75 | $29.62 | |
| Revenue / Share | $5.58 | · | $5.89 | $5.56 | $5.01 | · | $5.81 | $5.68 | $5.31 | · | $5.64 | $5.72 | $5.56 | · | $5.49 | $5.75 | |
| Cash Flow / Share | $1.49 | · | · | · | $1.59 | · | · | · | $1.09 | · | · | · | $0.96 | · | · | · | |
| Cash / Share | $1.58 | · | $1.11 | $2.12 | $2.48 | · | $0.91 | $0.92 | $0.61 | · | $1.15 | $1.09 | $0.99 | · | $1.57 | $0.78 | |
| EPS (TTM) | $3.57 | · | $3.78 | $4.03 | $4.26 | · | $4.27 | $4.11 | $4.09 | · | $-1.61 | $-1.63 | $-1.68 | · | $4.17 | $4.12 |
Değerleme (TTM)
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.10B | · | $1.10B | $1.11B | $1.12B | · | $1.12B | $1.11B | $1.11B | · | $1.13B | $1.13B | $1.13B | · | $1.11B | $1.11B | |
| Net Income TTM | $172M | · | $187M | $201M | $213M | · | $214M | $206M | $205M | · | $-81M | $-82M | $-84M | · | $210M | $209M | |
| Market Cap | $2.66B | · | $3.47B | $3.51B | $4.49B | · | $4.37B | $4.02B | $3.84B | · | $3.39B | $3.16B | $3.28B | · | $3.43B | $2.73B | |
| Enterprise Value | $4.59B | · | · | · | · | · | $5.32B | $5.03B | $4.90B | · | $4.53B | $4.38B | $4.56B | · | $4.79B | $4.14B | |
| P/E | 13.2 | · | 16.3 | 15.5 | 18.7 | · | 18.3 | 17.5 | 16.8 | · | -38.0 | -35.1 | -35.4 | · | 15.0 | 12.1 | |
| P/S | 2.4 | · | 3.1 | 3.2 | 4.0 | · | 3.9 | 3.6 | 3.4 | · | 3.0 | 2.8 | 2.9 | · | 3.1 | 2.5 | |
| P/B | 1.4 | · | 1.9 | 1.9 | 2.4 | · | 2.4 | 2.3 | 2.3 | · | 2.1 | 2.1 | 2.2 | · | 2.0 | 1.7 | |
| P / Cash Flow | 37.6 | · | · | · | 56.8 | · | · | · | 70.0 | · | · | · | 68.2 | · | · | · | |
| EV / Revenue | 4.2 | · | · | · | · | · | 4.8 | 4.5 | 4.4 | · | 4.0 | 3.9 | 4.0 | · | 4.3 | 3.7 | |
| Earnings Yield | 7.5% | · | 6.1% | 6.5% | 5.3% | · | 5.5% | 5.7% | 5.9% | · | -2.6% | -2.9% | -2.8% | · | 6.7% | 8.3% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Gelir | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B |
| Brüt Kâr Marjı % | 54.7% | 55.8% | 55.5% | 55.5% | 57.1% |
| Faaliyet Kâr Marjı % | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% |
| Net Gelir | $190M | $215M | $209M | $-82M | $205M |
| Seyreltilmiş Hisse Başı Kâr | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 |
| Metrik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | · | · | 0.7 | 0.9 | 0.9 |
| Cari Oran | 3.6 | 4.2 | 3.2 | 2.4 | 2.0 |
| Cari Oran | 2.1 | 2.7 | 1.9 | 1.4 | 1.2 |
| Metrik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $246M | $243M | $239M | $222M | $250M |
Kurumsal Sahipler (13F) 340 dosya · $2.9B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 39 (-19 önceki Ç'ye göre) | 69 (+29 önceki Ç'ye göre) | 108 (-17 önceki Ç'ye göre) | 119 (-10 önceki Ç'ye göre) | +2.2M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BlackRock, Inc. | $370.187.111 | 7.831.333 | 12,99% | Hisse senetleri |
| VANGUARD GROUP INC | $332.432.481 | 5.388.758 | 11,66% | Hisse senetleri |
| ARIEL INVESTMENTS, LLC | $230.143.970 | 4.868.711 | 8,07% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $133.553.822 | 2.825.340 | 4,69% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $125.802.061 | 2.661.291 | 4,41% | Hisse senetleri |
| FULLER & THALER ASSET MANAGEMENT, INC. | $110.225.175 | 2.331.821 | 3,87% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $101.013.343 | 2.136.944 | 3,54% | Hisse senetleri |
| STATE STREET CORP | $100.047.570 | 2.116.513 | 3,51% | Hisse senetleri |
| BRANDES INVESTMENT PARTNERS, LP | $96.953.606 | 2.051.060 | 3,40% | Hisse senetleri |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $88.490.528 | 1.872.023 | 3,10% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $74.306.032 | 1.571.742 | 2,61% | Hisse senetleri |
| Allspring Global Investments Holdings, LLC | $61.257.112 | 1.271.950 | 2,15% | Hisse senetleri |
| MORGAN STANLEY | $58.800.671 | 1.243.931 | 2,06% | Hisse senetleri |
| NORDEA INVESTMENT MANAGEMENT AB | $39.252.108 | 828.628 | 1,38% | Hisse senetleri |
| NORTHERN TRUST CORP | $36.560.934 | 773.449 | 1,28% | Hisse senetleri |
| WESTWOOD HOLDINGS GROUP INC | $35.473.535 | 750.445 | 1,24% | Hisse senetleri |
| RICE HALL JAMES & ASSOCIATES, LLC | $32.601.741 | 689.692 | 1,14% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $31.134.811 | 658.659 | 1,09% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30.922.805 | 654.174 | 1,08% | Hisse senetleri |
| UBS Group AG | $30.186.858 | 638.605 | 1,06% | Hisse senetleri |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $29.772.348 | 629.836 | 1,04% | Hisse senetleri |
| Boston Trust Walden Corp | $28.832.289 | 609.949 | 1,01% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $27.725.541 | 586.536 | 0,97% | Hisse senetleri |
| CITADEL ADVISORS LLC | $26.667.701 | 564.157 | 0,94% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $26.277.109 | 555.894 | 0,92% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $21.949.967 | 464.353 | 0,77% | Hisse senetleri |
| Leeward Investments, LLC - MA | $20.700.289 | 437.916 | 0,73% | Hisse senetleri |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $19.921.578 | 421.440 | 0,70% | Hisse senetleri |
| Invesco Ltd. | $19.209.111 | 406.370 | 0,67% | Hisse senetleri |
| Woodline Partners LP | $17.004.012 | 359.721 | 0,60% | Hisse senetleri |
| ARMISTICE CAPITAL, LLC | $15.882.720 | 336.000 | 0,56% | Hisse senetleri |
| Glenmede Investment Management, LP | $15.685.425 | 251.369 | 0,55% | Hisse senetleri |
| Bank of New York Mellon Corp | $15.375.752 | 325.275 | 0,54% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $14.837.438 | 313.887 | 0,52% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $14.832.286 | 313.778 | 0,52% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $14.604.614 | 308.962 | 0,51% | Hisse senetleri |
| Nuveen, LLC | $14.012.435 | 296.434 | 0,49% | Hisse senetleri |
| Congress Wealth Management LLC / DE / | $13.030.320 | 163.185 | 0,46% | Hisse senetleri |
| PRINCIPAL FINANCIAL GROUP INC | $12.700.693 | 268.684 | 0,45% | Hisse senetleri |
| Tributary Capital Management, LLC | $11.958.554 | 252.984 | 0,42% | Hisse senetleri |
| Fisher Asset Management, LLC | $11.698.136 | 247.474 | 0,41% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $11.013.816 | 232.998 | 0,39% | Hisse senetleri |
| PRUDENTIAL FINANCIAL INC | $10.251.209 | 216.865 | 0,36% | Hisse senetleri |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $10.122.871 | 214.150 | 0,36% | Hisse senetleri |
| JPMORGAN CHASE & CO | $10.050.950 | 207.249 | 0,35% | Hisse senetleri |
| Aristotle Capital Boston, LLC | $10.043.458 | 212.470 | 0,35% | Hisse senetleri |
| ENVESTNET ASSET MANAGEMENT INC | $9.983.703 | 211.206 | 0,35% | Hisse senetleri |
| FMR LLC | $9.951.172 | 210.518 | 0,35% | Hisse senetleri |
| GLENMEDE TRUST CO NA | $9.729.017 | 205.818 | 0,34% | Hisse senetleri |
| JENNISON ASSOCIATES LLC | $9.393.259 | 198.715 | 0,33% | Hisse senetleri |
Şirket yöneticileri 50 içeriden öğrenenler · 29 yöneticiler · 18 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Ronald M. Lombardi | Chief Executive Officer | 07 Mayıs 2026 F | 373.465 | 0 | 0 | $0 |
| Matthew Mannelly | President and CEO | 01 Haziran 2015 M | 27.706 | 0 | 0 | $0 |
| Mark Pettie | Chairman and CEO | 03 Mart 2009 P | 177.168 | 0 | 0 | $0 |
| Frank Palantoni | CEO and President | 19 Mayıs 2006 P | 33.278 | 0 | 0 | $0 |
| Christine Sacco | CFO & COO | 02 Mayıs 2026 F | 57.374 | 0 | 0 | $0 |
| David S Marberger | Chief Financial Officer | 09 Mayıs 2016 A | 11.050 | 0 | 0 | $0 |
| Peter Anderson | Chief Financial Officer | 25 Mayıs 2010 D | 401.850 | 0 | 0 | $0 |
| Jeffrey Zerillo | Senior VP Operations | 11 Mayıs 2026 S | 41.810 | 0 | 7 | $-246.374 |
| Adel Mekhail | EVP, Marketing & Sales | 07 Mayıs 2026 F | 25.703 | 0 | 0 | $0 |
| William P'Pool | SVP, General Counsel & Corp Secretary | 04 Mayıs 2026 A | 28.149 | 0 | 0 | $0 |
| Jose Luis Rosado | SVP-Quality & Regulatory Affairs | 06 Ocak 2026 A | 3.436 | 0 | 0 | $0 |
| Mary Beth Fritz | SVP Quality & Regulatory | 07 Mayıs 2025 F | 17.051 | 0 | 0 | $0 |
| Timothy Connors | EVP, Sales & Marketing | 09 Mayıs 2019 F | 21.717 | 0 | 0 | $0 |
| Jean A Boyko | SVP, Science and Technology | 15 Mayıs 2018 M | 11.081 | 0 | 0 | $0 |
| Christopher Heye | Senior Vice President-Canada, Women's Health and Strategic Planning. | 07 Mayıs 2018 A | 8.150 | 0 | 0 | $0 |
| Thomas Hochuli | Vice President, Operations | 14 Ağustos 2017 F | 6.678 | 0 | 0 | $0 |
| John Parkinson | Senior VP- International | 12 Mayıs 2017 F | 62.075 | 0 | 0 | $0 |
| Paul Migaki | VP of Strategic Planning/Canada | 27 Mayıs 2016 M | 55.927 | 0 | 0 | $0 |
| Samuel C Cowley | General Counsel and VP | 27 Mayıs 2016 M | 32.176 | 0 | 0 | $0 |
| Paul A. Hennessey | Vice President, Operations | 21 Mayıs 2014 M | 15.282 | 0 | 0 | $0 |
| Eric S. Klee | Secretary and General Counsel | 30 Mayıs 2011 F | 13.236 | 0 | 0 | $0 |
| David Talbert | Senior Vice President, Sales | 25 Mayıs 2010 D | 28.331 | 0 | 0 | $0 |
| Lieven Nuyttens | Senior VP, Operations | 25 Mayıs 2010 D | 16.640 | 0 | 0 | $0 |
| Charles Jolly | Secretary and General Counsel | 31 Mart 2009 D | 30.579 | 0 | 0 | $0 |
| Charles Schrank | Chief Mktg. Officer/Household | 31 Mart 2009 D | 90.846 | 0 | 0 | $0 |
| James E Kelly | SVP - Chief Marketing Officer | 30 Mayıs 2008 A | 27.427 | 0 | 0 | $0 |
| Gerard Butler | Chief Sales Officer | 02 Ocak 2007 D | 289.172 | 0 | 0 | $0 |
| Michael Fink | Senior V.P. of Marketing | 15 Şubat 2005 S | 180.560 | 0 | 0 | $0 |
| Eric Millar | Senior V.P. of Operations | 15 Şubat 2005 S | 72.347 | 0 | 0 | $0 |
| Sheila Hopkins | Yönetim kurulu üyesi | 05 Ağustos 2025 A | 30.123 | 0 | 0 | $0 |
| Natale S Ricciardi | Yönetim kurulu üyesi | 01 Ağustos 2023 A | 27.098 | 0 | 0 | $0 |
| COUGHLIN CHRISTOPHER J | Yönetim kurulu üyesi | 02 Ağustos 2022 A | 13.218 | 0 | 0 | $0 |
| James M Jenness | Yönetim kurulu üyesi | 04 Ağustos 2020 A | 22.791 | 0 | 0 | $0 |
| Carl J Johnson | Yönetim kurulu üyesi | 31 Temmuz 2018 A | 14.598 | 0 | 0 | $0 |
| Charles Hinkaty | Yönetim kurulu üyesi | 04 Ağustos 2015 A | 31.714 | 0 | 0 | $0 |
| Patrick Lonergan | Yönetim kurulu üyesi | 10 Aralık 2012 G | 37.323 | 0 | 0 | $0 |
| John Byom | Yönetim kurulu üyesi | 03 Ağustos 2010 A | 29.755 | 0 | 0 | $0 |
| Vincent J Hemmer | Yönetim kurulu üyesi | 10 Eylül 2009 J | 80.410 | 0 | 0 | $0 |
| Peter Mann | Yönetim kurulu üyesi | 04 Ağustos 2009 A | 447.700 | 0 | 0 | $0 |
| Dick L Buell | Yönetim kurulu üyesi | 04 Ağustos 2009 A | 27.662 | 0 | 0 | $0 |
| David Donnini | Yönetim kurulu üyesi | 29 Mayıs 2009 S | 0 | 0 | 0 | $0 |
| Ronald B Gordon | Yönetim kurulu üyesi | 05 Ağustos 2008 A | 30.352 | 0 | 0 | $0 |
| Raymond Silcock | Yönetim kurulu üyesi | 05 Ağustos 2008 A | 16.249 | 0 | 0 | $0 |
| John F. Kelly | · | 04 Ağustos 2026 A | 7.832 | 0 | 0 | $0 |
| James Darecca | · | 04 Ağustos 2026 A | 9.572 | 0 | 0 | $0 |
| Dawn M. Zier | · | 04 Ağustos 2026 A | 19.514 | 0 | 0 | $0 |
| Celeste A. Clark | · | 04 Ağustos 2026 A | 16.511 | 0 | 0 | $0 |
| John E Byom | · | 04 Ağustos 2026 A | 54.575 | 0 | 1 | $-178.050 |
| COSTLEY GARY E | · | 04 Ağustos 2020 A | 50.200 | 0 | 0 | $0 |
| GTCR GOLDER RAUNER II LLC | · | 29 Mayıs 2009 S | 0 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 67 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 2,83% | 347.516 SH | 02 Ekim 2026 | Günlük |
| PILL · Direxion Shares ETF Trust | 1,16% | 4.781 NS | 31 Temmuz 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,16% | 44.987 SH | 02 Ekim 2026 | Günlük |
| HSMV · First Trust Exchange-Traded Fund III | 0,80% | 5.597 NS | 31 Temmuz 2026 | N-PORT |
| FYT · First Trust Exchange-Traded AlphaDE… | 0,65% | 25.280 NS | 31 Temmuz 2026 | N-PORT |
| SCOW · Pacer Funds Trust | 0,59% | 201 NS | 31 Temmuz 2026 | N-PORT |
| CAFG · Pacer Funds Trust | 0,52% | 3.105 NS | 31 Temmuz 2026 | N-PORT |
| IHE · iShares Trust | 0,51% | 175.342 SH | 11 Eylül 2026 | Günlük |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,34% | 92.272 NS | 31 Temmuz 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,25% | 181.211 NS | 31 Temmuz 2026 | N-PORT |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,24% | 100.520 SH | 19 Ağustos 2026 | Günlük |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 18.534 NS | 31 Temmuz 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,15% | 41.965 SH | 19 Ağustos 2026 | Günlük |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,14% | 7.601 SH | 02 Ekim 2026 | Günlük |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,13% | 4.372 NS | 31 Temmuz 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,12% | 165.811 SH | 19 Ağustos 2026 | Günlük |
| ROSC · Lattice Strategies Trust | 0,12% | 1.466 NS | 31 Temmuz 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,12% | 195.077 NS | 31 Temmuz 2026 | N-PORT |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,12% | 8.172 SH | 02 Ekim 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,11% | 66.578 SH | 02 Ekim 2026 | Günlük |
| EBIT · Harbor ETF Trust | 0,11% | 258 NS | 31 Temmuz 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,10% | 1.747 NS | 31 Temmuz 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,09% | 43.685 NS | 31 Temmuz 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 11.789 NS | 31 Temmuz 2026 | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 0,08% | 7.246 SH | 19 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,08% | 22.923 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,07% | 1.227.360 SH | 11 Eylül 2026 | Günlük |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,07% | 175.325 SH | 19 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 275.721 SH | 19 Ağustos 2026 | Günlük |
| DFAT · Dimensional ETF Trust | 0,07% | 196.959 NS | 31 Temmuz 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,07% | 28.777 SH | 02 Ekim 2026 | Günlük |
| VBR · VANGUARD INDEX FUNDS | 0,05% | 690.582 SH | 19 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,05% | 152.317 NS | 31 Temmuz 2026 | N-PORT |
| IGRO · iShares Trust | 0,05% | 10.967 SH | 11 Eylül 2026 | Günlük |
| WSML · iShares Trust | 0,04% | 5.420 SH | 11 Eylül 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 22.700 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 544.134 SH | 19 Ağustos 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,03% | 1.087.231 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,03% | 142.413 SH | 19 Ağustos 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,01% | 117.382 NS | 31 Temmuz 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,01% | 36.640 NS | 31 Temmuz 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 5.233 NS | 31 Temmuz 2026 | N-PORT |
| VXUS · VANGUARD STAR FUNDS | 0,01% | 688.472 SH | 19 Ağustos 2026 | Günlük |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,01% | 453.610 SH | 19 Ağustos 2026 | Günlük |
| VSGX · VANGUARD WORLD FUND | 0,01% | 9.203 SH | 19 Ağustos 2026 | Günlük |
| IDEV · iShares Trust | 0,01% | 52.014 SH | 11 Eylül 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,01% | 829 NS | 31 Temmuz 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 3.004 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 4.442 NS | 31 Temmuz 2026 | N-PORT |
| IXUS · iShares Trust | 0,01% | 56.667 SH | 11 Eylül 2026 | Günlük |
| ITOT · iShares Trust | 0,00% | 69.137 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 14.019 SH | 11 Eylül 2026 | Günlük |
| DFAU · Dimensional ETF Trust | 0,00% | 6.651 NS | 31 Temmuz 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 10.940 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.510.012 SH | 19 Ağustos 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 69.368 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.089 SH | 19 Ağustos 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,00% | 10.506 SH | 19 Ağustos 2026 | Günlük |
| IJR · iShares Trust | · | 2.889.316 SH | 10 Eylül 2026 | Günlük |
| IJS · iShares Trust | · | 422.466 SH | 08 Eylül 2026 | Günlük |
| IWN · iShares Trust | · | 449.434 SH | 11 Eylül 2026 | Günlük |
| XJR · iShares Trust | · | 6.541 SH | 31 Ağustos 2026 | Günlük |
| SVAL · iShares Trust | · | 10.792 SH | 03 Eylül 2026 | Günlük |
| ISCB · iShares Trust | · | 1.977 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 9.565 SH | 11 Eylül 2026 | Günlük |
| SMLF · iShares Trust | · | 38.488 SH | 11 Eylül 2026 | Günlük |
| SMMV · iShares Trust | · | 20.132 SH | 25 Ağustos 2026 | Günlük |
PBH Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
12 Aylık Fiyat Hedefi
5 analist · 2026-10-03Ortalama hedef $67.80 +49,8%
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | · |
| AMRX | · | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| HRMY | $2.16B | 13.8 | 21.5% | 18.3% | 19.3% | 77.2% |
| GPCR | $14.78B | -86.9 | · | · | -12.3% | · |
| TRLV | · | · | -0.45% | -10.3% | -10.4% | 60.2% |
| TRVI | $1.61B | -39.1 | · | · | -22.4% | · |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | · |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.